Home/Filings/4/0001127602-24-027976
4//SEC Filing

Dahiyat Bassil I 4

Accession 0001127602-24-027976

CIK 0001326732other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 4:04 PM ET

Size

12.6 KB

Accession

0001127602-24-027976

Insider Transaction Report

Form 4
Period: 2024-11-21
Dahiyat Bassil I
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-11-2149,27822,356 total
    Exercise: $15.69Exp: 2025-02-11Common Stock (49,278 underlying)
  • Exercise/Conversion

    Common Stock

    2024-11-21$15.69/sh+49,278$773,172401,893 total
  • Sale

    Common Stock

    2024-11-21$24.07/sh49,278$1,186,363352,615 total
  • Exercise/Conversion

    Common Stock

    2024-11-22$15.69/sh+13,548$212,568366,163 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-11-2213,5488,808 total
    Exercise: $15.69Exp: 2025-02-11Common Stock (13,548 underlying)
Footnotes (3)
  • [F1]This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 14, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.203, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]25% of the shares subject to the option vested on the one year anniversary of February 12, 2015 (the "Vesting Commencement Date"), and 1/48th of the shares vested monthly thereafter, such that the option was fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.

Issuer

Xencor Inc

CIK 0001326732

Entity typeother

Related Parties

1
  • filerCIK 0001591312

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:04 PM ET
Size
12.6 KB